NCT02842424View on ClinicalTrials.gov

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Ramipril

Ramipril therapy will start at 2.5mg/day for 1 week. Then 5mg/day for 1 week and will be increased to 10mg/day by the third week. The patients will stay on Ramipril 10mg/day for 22 weeks.

Trial Locations (1)

68105

RECRUITING

VA Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER